The Misconception About Quality

Let’s start with the elephant in the room: in many biotech organizations, the Quality department is seen as the “no” department. “No, you can’t do that.” “No, that’s not compliant.” “No, not until we finish validation.”

I’ve lived this. I’ve seen the eye rolls when QA walks into a meeting or the sighs when a regulatory question puts the brakes on a fast-moving idea. And yet, I’ve also seen firsthand how the most innovative companies are the ones that understand that true innovation doesn’t happen in spite of compliance—it thrives because of it.

Throughout my career—from early HIV diagnostic test development to cell therapies and medical devices—I’ve come to believe that our role as quality leaders is not to be the gatekeepers of “no,” but the enablers of smart, sustainable innovation. That starts with shifting the mindset—from compliance as a constraint to quality as a confidence-builder.

Building the Foundation for Bold Ideas

Great ideas in biotech don’t start in isolation—they start in cross-functional conversations. When I’ve seen innovation truly take off, it’s because scientists, engineers, quality professionals, and regulatory experts are sitting at the same table from day one.

That means building a culture where QA and RA are not brought in at the end to clean up the mess or “check the boxes,” but are integrated from the start. When quality professionals are part of early development conversations, we can help design processes that are not only compliant but also scalable, efficient, and ready for what’s next.

For example, when I led Quality at Just Biotherapeutics, we built a greenfield manufacturing facility in 18 months—during COVID. That kind of timeline would’ve been impossible without embedding quality into every phase, from construction to validation. We didn’t cut corners. We built confidence.

Empowering Teams with “Why”

One of the most powerful tools I’ve used to inspire innovation is education—not just about what needs to be done, but why it matters. People don’t connect to policies. They connect to purpose.

When teams understand the why behind a regulatory requirement or a validation protocol, they’re far more likely to engage, contribute ideas, and innovate within those boundaries. I’ve spent many hours walking teams through the rationale behind GMP standards, explaining the risk-based thinking behind our change controls, or showing how one missed deviation could impact a patient’s experience.

The result? Teams that don’t just follow the rules but take ownership of them. That’s when compliance becomes confidence.

Saying “Yes, If” Instead of “No”

I’ve found that language matters—a lot. Instead of defaulting to “no,” I’ve trained myself and my teams to say “yes, if…”

“Yes, if we can validate this step.”
“Yes, if we update the risk assessment.”
“Yes, if we bring RA into the loop now.”

This approach not only preserves quality standards but fosters collaboration. It keeps the door open to progress and positions QA as a partner in problem-solving. We’re not there to slow down science—we’re there to help it succeed without creating risk down the road.

This shift is especially important in high-stakes fields such as cell and gene therapy, where development is outpacing regulations. In those cases, we must lead with critical thinking, apply scientific judgment, and navigate uncertainty with both rigor and creativity.

Modeling Calm in the Chaos

Let’s be honest—this work can be stressful—inspections, deadlines, changing guidance, and the ever-present pressure to get products to patients. But one of the most important leadership lessons I’ve learned is this: if you stay calm, your team will follow.

Confidence is contagious. When I walk into a meeting or an audit with clarity and composure, it creates a sense of stability. My team knows I have their back. And more importantly, they know I trust them. That trust creates space for innovation because people feel safe speaking up, sharing new ideas, and raising concerns early.

That kind of psychological safety is the secret sauce behind high-performing quality teams. It doesn’t come from micromanagement. It comes from trust, mentorship, and leading by example.

Measuring Success Beyond Checklists

One of the most meaningful metrics I’ve tracked over the years isn’t found on a dashboard—it’s staff retention. I’m proud to say I’ve maintained a 95%+ retention rate across many years of leading quality teams. Why? Because people stay where they feel heard, challenged, and valued.

Yes, we pass audits. Yes, we get products approved. But even more rewarding is seeing a junior QA associate grow into a confident manager, or watching a regulatory specialist take the lead on a successful submission. That’s how I measure success.

Quality as a Launchpad

To all my fellow leaders in biotech and life sciences: let’s change the narrative around quality. Let’s stop seeing it as a barrier and start using it as a launchpad for smarter systems, better products, and more empowered people.

Compliance and innovation are not opposites. The best innovation happens when you’re grounded in a system you trust. Quality is not about control—it’s about confidence.

And when your team feels confident, they won’t just follow the path—they’ll help build the future.

The post From Compliance to Confidence: How Quality Leaders Can Inspire Innovation Without Compromising Standards appeared first on Donna Matuizek.

Why Culture Matters in Quality-Driven Workplaces

When people think of careers in biotech, they often picture labs, SOPs, audits, and regulatory checklists—and they’re not wrong. But behind every approval and inspection-ready system is a team of people, and how those people feel about their work—and each other—can make or break performance.

In Quality Assurance and Regulatory Affairs, our job is to ensure that every product is safe, effective, and meets all necessary requirements. But what I’ve learned after decades in the field is that quality doesn’t come from documents alone—it comes from a culture of collaboration, trust, and pride in doing things right.

That’s why I’ve always looked for creative ways to build and nurture team culture. One of my favorites? Believe it or not—wine tasting.

Beyond the Cubicle: Connection Outside of Compliance

At one point in my career, I led a rapidly growing QA and QC team tasked with qualifying a new clinical manufacturing facility. We were working long hours, facing tight deadlines, and preparing for client audits. Morale could have easily slipped—but instead, something incredible happened: we bonded.

Part of that came from creating intentional spaces for connection outside of work tasks. I started organizing small after-hours events—nothing extravagant, just a chance to unwind and connect. One night, it was a DIY cooking class; another time, a garden party at my house; and one particularly memorable evening—a team wine tasting at a local spot that I love.

You might think wine tasting sounds indulgent or unrelated to quality systems, but hear me out. It’s about shared experiences. When people laugh together, learn something new side-by-side, or simply spend time outside of their “work roles,” they return to the workplace more connected, more open, and often—more motivated.

The Power of Shared Experiences

In quality-driven environments, communication is critical. Whether you’re managing a deviation investigation, preparing for an FDA inspection, or validating a manufacturing line, you need team members to speak up, support each other, and trust the process—and one another.

The best way I’ve found to foster that kind of environment is to build genuine relationships. Events like team dinners, themed potlucks, or even informal wine tastings aren’t about the activity—they’re about creating a moment where hierarchy drops away and people can simply be themselves.

Some of the best cross-functional collaboration I’ve seen started over cheese boards and conversation. It may not show up in a CAPA report, but it certainly shows up in how well people communicate and problem-solve on the floor.

Making It Inclusive and Intentional

That said, not everyone drinks wine—and that’s okay! The point isn’t alcohol, it’s the connection. I’ve made sure our events always have something for everyone—mocktails, tea tastings, dessert pairings, or garden tours. Inclusivity is key. The goal is to make sure everyone feels welcome, included, and appreciated.

We’ve also done “lunch & learns” on food safety, team-building cook-offs, and even a book club on leadership books. It doesn’t have to cost a lot or take hours of planning. What matters is the intent behind it: to remind people they’re valued and to create opportunities for informal connection that carry back into the workday.

Culture Supports Compliance

When people feel connected and cared for, they take more ownership of their work. I’ve seen this play out time and time again—teams that feel like a community are quicker to identify and solve problems, more resilient during audits, and more engaged in process improvements.

That’s not just feel-good leadership—it’s strategic. Regulatory success depends on consistency, attention to detail, and accountability. And those qualities thrive in environments where people feel supported. Culture supports compliance.

It’s why I’ve always advocated for investing in both systems and people. Build your QMS, yes—but also build your team’s sense of purpose and camaraderie. They’re equally important.

Personal Joy, Professional Payoff

Bringing personal passions into professional spaces is part of what’s made my leadership style unique. My love of cooking, gardening, and yes—wine—hasn’t stayed at home. I’ve found ways to weave those joys into my work life, and in doing so, I’ve connected with my teams on a human level.

When you show up as a whole person, you give others permission to do the same. I’ve had team members open up about their love of painting, their side baking business, or their family traditions—and we’ve celebrated all of it. Those conversations have led to deeper trust, better collaboration, and, I’d argue, better results.

Small Gestures, Big Impact

You don’t need a huge budget or a formal HR initiative to cultivate a strong culture. Sometimes all it takes is offering your team a break, a laugh, and a toast to the work they’ve done. Whether it’s over wine or water, what matters is the message: You matter. Your work matters. And we’re in this together.

So here’s my advice—host that tasting, plan that potluck, organize a walking meeting or garden lunch. Create space for people to breathe. You’ll be surprised at how far a little connection goes toward building stronger, more resilient, quality-driven organizations.

And if you ever need a wine pairing recommendation for your next audit celebration—I’m your girl.

Cheers to culture, compliance, and community.

The post Wine Tasting and Team Building: Creative Ways to Foster Culture in Quality-Driven Organizations By Donna Matuizek appeared first on Donna Matuizek.

The Balancing Act of Biotech

Working in biotech and life sciences is rewarding—but let’s be honest, it’s also incredibly demanding. Between preparing for FDA inspections, meeting regulatory deadlines, managing teams, and keeping up with evolving guidance and technologies, the pressure can be intense. Over the years, I’ve learned that while the work can be high-stakes, finding balance is not only possible—it’s essential.

I’ve spent decades in Quality Assurance, Quality Control, and Regulatory Affairs roles, leading audits, building systems from the ground up, and helping bring groundbreaking therapies to market. But I’ve also spent evenings in my kitchen experimenting with a new risotto recipe, sipping a crisp white wine at a neighborhood wine bar, or laughing with friends at our monthly supper club. And through it all, I’ve discovered that managing stress and achieving success aren’t opposites—they’re two sides of the same coin.

When the Pressure’s On

There’s nothing quite like the anticipation of an FDA inspection. No matter how prepared your team is or how robust your systems are, it’s natural to feel the weight of what’s at stake. I’ve led teams through 5-day inspections, participated in global audits, and hosted more client visits than I can count. Each one brings a mix of adrenaline, focus, and yes—stress.

But I’ve found that the key to managing those high-pressure moments is preparation and mindset. Preparation means systems that work, documentation that tells a clear story, and people who know their roles and responsibilities. Mindset means trusting that work, keeping a sense of perspective, and staying calm and collected, even if things go sideways. Stress can be a motivator, but if it’s unmanaged, it becomes a barrier.

Building Resilient Teams

One of the most powerful tools for managing stress at work is building a resilient team culture. I’ve always emphasized transparency, shared accountability, and celebrating the wins—big or small. When your team feels supported and knows they can speak up, you create an environment where people are more confident, more engaged, and less anxious when the pressure rises.

That’s how we got through building and qualifying an entire commercial manufacturing facility during COVID—because the team had each other’s backs. We weren’t just focused on getting it done; we were focused on doing it right, together.

The Role of Ritual and Routine

Outside of work, I’ve developed personal routines that help me recharge and reset. For me, cooking isn’t just a hobby—it’s therapy. There’s something so grounding about chopping vegetables, stirring a sauce, and creating something beautiful and nourishing from simple ingredients. It’s the opposite of the fast-paced, high-stakes world of biotech. It slows me down and brings me back to myself.

Wine is another joy of mine—whether it’s discovering a new varietal or sharing a bottle with friends after a long week. Aperitifs may seem like a small thing, but they represent something bigger: a pause. A signal that it’s okay to unwind, to reflect, to laugh, and to enjoy the fruits of your labor.

Letting Go of Perfection

One of the biggest lessons I’ve learned in this field is that perfection isn’t the goal—resilience is. Things go wrong. Data can surprise you. People make mistakes. The question isn’t whether you’ll face setbacks, but how you’ll respond. And for me, responding starts with grace—both for myself and for my team.

That means letting go of unrealistic expectations. That means saying no sometimes. That means not answering emails at 10 PM every night. And it means creating space for rest, creativity, and connection—because those are the things that fill your cup and make you better at your job in the long run.

Celebrating the Wins

Success in life sciences can sometimes feel anticlimactic. You work for months—sometimes years—on a product or project, and the “approval” arrives quietly in an email or a line in a report. That’s why I make it a point to celebrate—every successful audit, every cleared submission, every time a team member steps into a leadership role. We mark those moments with a toast, a team lunch, or simply by saying “great job.”

Recognizing effort is as important as recognizing outcomes. And when we acknowledge those wins, we reinforce the value of the work and the people doing it.

Finding Your Own Version of Balance

Everyone’s balance looks different. For me, it’s gardening on weekends, book club debates over homemade meals, early morning walks, and trying out new restaurants with friends. It’s taking time to be more than a title or a role. It’s being fully present in both the lab and the living room.

If you’re early in your career, I encourage you to find those rituals and passions outside of work that ground you. If you’re a leader, model balance for your team. Let them see that high performance and well-being can coexist. Because at the end of the day, the goal isn’t just regulatory approval—it’s building a life you’re proud of, both professionally and personally.

Final Thoughts

In the world of life sciences, stress will always be part of the job. But with preparation, strong teams, and personal rituals that bring you joy, you can navigate the pressure with clarity and calm. And maybe even enjoy a good meal and a glass of wine along the way.

Here’s to the audits, the approvals—and the aperitifs.

The post Audits, Approvals, and Aperitifs: Managing Stress and Success in Life Sciences Careers By Donna Matuizek appeared first on Donna Matuizek.

A Seat at the Table

When I started my career in the biotech and life sciences industry, there weren’t many women in leadership—especially not in Quality Assurance, Regulatory Affairs, or technical operations. Most of the time, I was the only woman in the room during inspections, audits, or executive planning sessions. But over the decades, that landscape has changed—and I’m proud to say I’ve been part of that evolution.

As someone who has led quality and regulatory teams across companies developing everything from in vitro diagnostics to cell therapies, I’ve seen firsthand the power of female leadership in shaping resilient, compliant, and innovative biotech organizations. Women bring a unique blend of empathy, attention to detail, communication, and calm under pressure. And in Quality and Compliance, those aren’t just helpful—they’re essential.

The Strength Behind the Scenes

Quality and Compliance often operate behind the scenes—but make no mistake, we’re the engine that helps companies deliver safe, effective therapies to patients. We build the systems that keep operations running smoothly. We respond to the regulators. We train the teams. We spot the gaps. And when something goes wrong, we’re the first ones called in.

That kind of responsibility requires resilience—not the kind that’s loud or showy, but the quiet, steady kind that doesn’t break under pressure. In my experience, many of the women I’ve worked with in this space carry that quiet strength. We lead with precision and passion. We hold the line, even when timelines are tight or pressure is high. And we bring teams together, knowing that true compliance comes from collaboration, not control.

Growing Teams, Growing Confidence

Throughout my career, I’ve had the opportunity to build Quality departments from the ground up—sometimes during startup phases, sometimes while scaling for commercial readiness. Each time, I’ve made it a priority to create environments where people feel empowered to speak up, share ideas, and grow into leadership roles themselves.

Many of the women I’ve hired and mentored over the years started in junior roles and rose to lead audits, manage systems, and drive global compliance strategies. I’ve seen firsthand how giving people the space to learn, fail safely, and be heard is the fastest way to build both confidence and competence. Empowerment is not a buzzword—it’s a strategy. And it works.

Designing for Resilience, Not Perfection

In biotech, nothing ever goes exactly to plan. There are pivots, surprises, and delays. Clinical results can change strategies overnight. Supply chain issues can ripple across multiple products. But if your quality and regulatory systems are built to adapt—if they’re designed for resilience—you can weather the storms.

I’ve been part of teams that built manufacturing sites during the height of COVID-19, completed successful FDA inspections on accelerated timelines, and helped secure market clearance for breakthrough medical devices. None of that happened because we were perfect. It happened because we were prepared. And preparation is something women in leadership tend to excel at. We think ahead. We scenario-plan. We ask the uncomfortable questions early. And we lead with both logic and heart.

The Power of Representation

One of the most powerful lessons I’ve learned is that simply being a woman in a leadership role makes a difference. I’ve had younger team members—especially women—pull me aside after meetings to say, “It’s so encouraging to see you lead the way you do.” And that matters.

Representation tells the next generation that there’s space for them at the top. That their voice matters. That they can lead while staying true to themselves. And that they don’t have to choose between a career in science and a fulfilling life outside of work. I’ve run marathons, cooked elaborate meals, traveled the world, and led companies through regulatory success. You don’t have to fit into one box.

Building the Future—Together

I truly believe that the future of biotech will be shaped by diverse voices and inclusive leadership. Quality and Compliance are fields that require constant learning, agility, and emotional intelligence. As the science gets more complex—think gene therapies, personalized medicine, and global supply chains—the people behind the scenes must be just as adaptable and forward-thinking.

I’ve seen more women stepping into VP and C-suite roles in Quality and Regulatory functions than ever before. We’re not just filling seats—we’re influencing policy, shaping strategy, and mentoring the next generation. And that ripple effect is powerful.

Lead with Purpose

If I could share one message with aspiring female leaders in biotech, it would be this: You belong here. Your perspective is valuable. And the way you lead—whether it’s quiet or bold, technical or people-focused—is needed.

Resilience isn’t about being unshakeable; it’s about staying grounded through uncertainty. And in the world of life sciences, where the stakes are high and the pace is fast, resilience is a superpower.

Lead with purpose. Lead with empathy. And never underestimate the impact you’re making—because the patients we serve are counting on all of us to get it right.

The post Resilient by Design: How Female Leaders in Biotech Are Shaping the Future of Quality and Compliance By Donna Matuizek appeared first on Donna Matuizek.

Introduction: Why Quality Culture Matters

If there’s one thing I’ve learned over the years in Quality and Regulatory Affairs, it’s that a successful company isn’t just built on strong systems but on strong people. In the life sciences industry, where patient safety and product integrity are non-negotiable, the culture of your team matters just as much as your processes. When it comes to retaining talented staff in Quality Assurance (QA), Quality Control (QC), and Regulatory roles, it all starts with empowerment.

Throughout my career—from helping establish the first FDA-cleared HIV blood screening test in the ’80s to overseeing new commercial biologics manufacturing sites during COVID—I’ve worked with teams of all sizes and structures. However, one consistent truth has remained: people who feel empowered stay longer, perform better, and become the backbone of an authentic quality culture.

Defining Quality Culture

So what is “quality culture”? For me, it’s a shared mindset across an organization where everyone, from the manufacturing floor to the executive team, understands and values the role of quality in everything they do. It’s not just about SOPs and audits—it’s about fostering pride, responsibility, and ownership in delivering safe, effective, and trusted products.

A healthy quality culture doesn’t happen by accident. It requires leadership, structure, and—most importantly—empowered people. When staff members feel that their voices are heard, their work is valued, and their growth is supported, they don’t just follow procedures—they believe in the mission behind them.

Empowerment Starts with Trust

Empowering a team begins with trust. When I stepped into leadership roles—like my time as VP of Quality at Just Biotherapeutics—I made it a point to lead with transparency and respect. I shared the “why” behind decisions, asked for input, and gave people room to make informed choices. That’s how you grow confident, capable team members.

Too often, I’ve seen organizations operate with a top-down, compliance-first mindset, where QA is perceived as the “department of no.” That’s a culture killer. Instead, I worked to position QA and Regulatory as collaborative partners—problem solvers, not obstacles. That shift alone can have a massive impact on morale and retention.

Investing in People, Not Just Processes

I’ve been fortunate to lead teams that maintained a greater than 95% staff retention rate over several years—and this wasn’t by luck. It was because we invested in people. That meant offering mentorship, ongoing training, and creating personal and professional growth space. Whether someone wanted to deepen their technical skills or try out a leadership track, we supported that journey.

One of the most effective things I ever did as a leader was regularly sitting down with team members—not just during annual reviews, but throughout the year—to ask how they were doing, what they wanted to learn, and how I could help. Sometimes the best empowerment comes from simply being seen and heard.

Recognition Goes a Long Way

In the fast-paced world of biotech and medical devices, getting wrapped up in deadlines and regulatory hurdles is easy. But recognizing your team’s big and small contributions goes a long way. Whether it’s celebrating a successful audit, acknowledging someone’s attention to detail in a deviation investigation, or just saying thank you after a long week, recognition builds a sense of belonging and value.

At Magnolia Medical Technologies, we celebrated every milestone—especially the tough ones, like getting FDA clearance on a Class II device during rapid growth. Those were shared wins, and we ensured the entire team felt that.

Empowerment During Tough Times

Empowerment is even more critical during challenges. During the COVID-19 pandemic, I led the Quality team through the full build-out of a new commercial facility—from greenfield to qualification—in just 18 months. That experience tested everything: timelines, supply chains, staffing, and morale. But because we had a strong, empowered team culture, we adapted, problem-solved, and ultimately succeeded.

We gave people space to raise concerns, encouraged flexible thinking, and let team members take ownership of parts of the project. That kind of trust created resilience. We didn’t just survive the pressure—we grew from it.

Building a Culture of Continuous Learning

In QA and Regulatory, things are constantly changing—new guidelines, new technologies, and new challenges. A team that’s empowered to learn will always be better positioned to adapt. I’ve always encouraged curiosity: ask questions, read the guidance documents, and shadow another team. Cross-training and development opportunities are some of the most effective retention tools out there.

At every company I’ve worked for—from Immunex to AGC Biologics—I’ve prioritized building quality teams that know more than just their job description. When people understand the full process—from research to release—they feel more connected to the mission.

Final Thoughts: Empowerment is a Strategy

If your organization struggles with retention in QA or Regulatory roles, I’d encourage you to closely examine your culture. Are your team members trusted? Are they growing? Do they feel like their work matters?

Empowerment isn’t a “soft” leadership style—it’s a strategy. It’s the foundation of a resilient team, a successful audit, and a product that makes it to market safely. In the life sciences, where the stakes are high and the work is significant, empowered teams don’t just stick around—they thrive.

Quality is everyone’s responsibility. But building a culture where that’s truly understood starts with how we lead, support, and uplift our people. When we get that right, everything else follows.

The post Quality Culture in the Life Sciences: Why Staff Retention Begins with Empowerment By Donna Matuizek appeared first on Donna Matuizek.

Where Science Meets Regulation

When I first stepped into the world of cell therapy back in the early 2000s, I knew I was entering a space where science was rapidly evolving. I didn’t fully realize just how complex the regulatory journey would be for these types of therapies. Unlike traditional pharmaceuticals, cell and gene therapies don’t follow a one-size-fits-all pathway. They’re living products, often personalized, making their development incredibly promising and challenging.

At Dendreon, I was part of the team that helped bring Provenge, the first FDA-approved cell therapy for prostate cancer, to market. It was a milestone moment, but it didn’t happen overnight. It took a deep understanding of regulatory expectations, tight collaboration across departments, and a commitment to doing things the right way—even when that meant taking the longer, harder road.

It Starts at the Bench

Cell and gene therapies usually start in a lab, often as a concept that seems far removed from the patient. But from the very beginning, I’ve learned it’s essential to think with the end in mind. If you’re working in research or early development, keep asking: How will this scale? How will it be manufactured consistently? What will regulators expect in terms of safety and efficacy?

Too many teams wait until clinical phases or commercial planning to seriously consider a regulatory strategy. But in this space, every decision, down to the materials used and the assays developed, can have regulatory implications. The earlier you bring in Quality and Regulatory Affairs, the better your chances of avoiding major roadblocks later.

Bridging Science and Systems

One of the biggest challenges in navigating the regulatory pathway is translating groundbreaking science into something that fits into a structured, compliant system. Cell therapies don’t behave like small or large molecules. They require custom manufacturing processes, aseptic environments, and validation approaches that often don’t have clear guidance.

That’s where strong Quality Systems come in. At Just Biotherapeutics, when we were building a new clinical manufacturing site, we knew we needed both compliant and adaptable systems. We had to document every process, validate every environment, and still allow for innovation. It’s a tricky balance, but it’s possible with the right team and mindset.

Regulators aren’t just looking for data—they’re looking for confidence—confidence that the process is controlled, the risks are managed, and the product will be safe for patients every single time. That comes from having a clear story and systems supporting it.

Regulatory Relationships Matter

When it comes to cell and gene therapies, the FDA and other global regulators aren’t just gatekeepers—they’re partners. I’ve participated in numerous audits and inspections over the years, and what stands out most is that regulators truly care about getting effective therapies to patients. They ask tough questions, yes—but they also want to help you succeed.

Early and ongoing engagement with regulators is essential for a cell therapy product. Don’t wait for the pre-IND meeting to start the conversation. Use every opportunity—type B meetings, scientific advice consultations, even informal dialogue—to clarify expectations and gain alignment. That communication can make or break your development timeline.

At Magnolia Medical Technologies, for example, we worked closely with the FDA to achieve clearance for a Class II next-generation medical device aimed at reducing false-positive sepsis diagnoses. That collaboration was key to getting the product across the finish line and getting the product to as many patients as fast as possible.

Your Team is Your Greatest Asset

Navigating the regulatory path for these therapies is not a solo job. It takes a committed, knowledgeable, and flexible team. At Dendreon, I helped build the Quality Control operation from the ground up and was later responsible for overseeing clinical product manufacturing at two contract manufacturing sites. None of that would have been possible without a dedicated cross-functional team—from scientists to engineers to regulatory specialists.

Resilience and communication are non-negotiable. The pace is fast, the expectations are high, and the science constantly evolves. I’ve always believed in investing in people, building a culture of trust, and empowering team members to take ownership of their role in the bigger picture. That kind of culture shows during an FDA inspection—and even more so during those everyday moments when you’re solving real problems under pressure.

Patients Are Always the Priority

Getting caught up in the technical and regulatory details is easy, but we can never forget why we’re doing this work. These therapies are not just products—they’re potential lifelines. At Dendreon, I met patients whose lives were extended because of Provenge. That changes the way you see everything. Every SOP, every deviation investigation, every batch record becomes part of a patient’s story.

That sense of purpose has kept me in this field for decades. Whether I’m reviewing a validation protocol, leading an audit, or mentoring a new QA manager, I always come back to this question: Would I want my loved one receiving this therapy? I know we’re doing it right if the answer is yes.

Final Thoughts

Cell and gene therapies represent the cutting edge of what’s possible in medicine. But with that potential comes complexity. Navigating the regulatory pathway isn’t easy, but it is achievable with the proper foundation: early planning, strong systems, open communication, and a patient-first mindset.

From my first days in biotech in the 1980s to leading quality efforts in new manufacturing builds, I’ve seen firsthand how powerful these therapies can be—and how important it is to get them right. If you’re working in this space, stay curious, compliant, and focused on the people waiting for the hope these therapies bring.

The path from bench to bedside is winding, but it’s worth walking together.

The post From Bench to Bedside: Navigating the Regulatory Pathway for Cell and Gene Therapies By Donna Matuizek appeared first on Donna Matuizek.